Well Well Well

4 Aug 2022

Monkeypox Updates from the International AIDS Conference 2022

Health, Men's Health, Sexual Health

Jack and Cal discuss what the International AIDS Conference is, what previous conferences have focused on, and what’s new this year.

Cal was at AIDS 2022 in Montreal, and he talks about the significant focus that Monkeypox had at the event.

We also hear from AFAO’s Acting CEO Heath Paynter and Thorne Harbour Health’s CEO Simon Ruth on Australia’s response to Monkeypox.

Since this episode was recorded, 450,000 doses of the third-generation Jynneos (AKA Imvamune or Imvanex) Monkeypox Vaccine have been procured by the Federal Government.

Federal Health Minister Mark Butler’s media release says the first delivery of roughly 22,000 doses will arrive in the country later this week.

Check out our other JOY Podcasts for more on HIV, COVID-19 and queer health & wellbeing.

If there’s something you’d like us to explore on the show, send through ideas or questions at wellwellwell@joy.org.au

Podcast: Play in new window | Download (Duration: 53:22 — 122.2MB) | Embed

Subscribe or Follow Us: Apple Podcasts | Spotify | Amazon Music | Android | iHeartRadio | Podchaser | Deezer | RSS

10 Dec 2025

Mainstream services supporting queer clients – 16 Days of Activism Series Part 5

Advocacy and Activism, Family Violence, Health, Thorne Harbour Health (VAC)

In the final episode of our 16 Days of Activism series, we're turning to the health and support systems themselves. We ...

10 Dec 2025

Supporting those who use harm to change – 16 Days of Activism Series Part 4

Advocacy and Activism, Family Violence, Health, Thorne Harbour Health (VAC)

Ending intimate partner and gender violence means supporting those who use harm to change. In this episode we explore what that ...

10 Dec 2025

Leaving a violent relationship – 16 Days of Activism Series Part 3

Advocacy and Activism, Family Violence, Health, Thorne Harbour Health (VAC)

Leaving a violent relationship is just the start. As we mark the 16 Days of Activism, we're talking about what it ...